Evofem Biosciences, Inc. (EVFM) SEC Filings & Financial Intelligence
Evofem Biosciences, Inc. (EVFM) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EVFM
CIK: 1618835
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BPM LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerKendall Kuhn
Audit LocationSacramento, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-09 | 8-K | 0001493152-26-047227 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-17 | 8-K | 0001493152-26-043919 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038328 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-04 | — | SCHEDULE 13D Filing | 0001213900-26-084888 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001493152-26-033910 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-08 | 8-K | 0001493152-26-033184 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001493152-26-024095 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023928 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-24 | 8-K | 0001493152-26-020417 | View SEC Doc Filr Page |
| 8-K | 2026-04-16 | 2026-04-10 | 8-K | 0001493152-26-017082 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-13 | 8-K | 0001493152-26-011613 | View SEC Doc Filr Page |
| 8-K | 2026-03-11 | 2026-03-11 | 8-K | 0001493152-26-009689 | View SEC Doc Filr Page |
| 10-K | 2026-03-11 | 2025-12-31 | 10-K | 0001493152-26-009686 | View SEC Doc Filr Page |
| 8-K | 2026-01-12 | 2026-01-12 | 8-K | 0001493152-26-001886 | View SEC Doc Filr Page |
| 8-K | 2025-11-26 | 2025-11-26 | 8-K | 0001493152-25-025172 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | 8-K | 0001493152-25-022318 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001493152-25-022275 | View SEC Doc Filr Page |
| DEF 14A | 2025-10-29 | 2025-10-29 | DEF 14A | 0001493152-25-020062 | View SEC Doc Filr Page |
| PRE 14A | 2025-10-20 | 2025-10-20 | PRE 14A | 0001493152-25-018688 | View SEC Doc Filr Page |
| 8-K | 2025-10-20 | 2025-10-20 | 8-K | 0001493152-25-018687 | View SEC Doc Filr Page |
| 8-K | 2025-10-17 | 2025-10-13 | 8-K | 0001493152-25-018454 | View SEC Doc Filr Page |
| DEFA14A | 2025-09-19 | — | DEFA14A | 0001493152-25-014327 | View SEC Doc Filr Page |
| DEFA14A | 2025-09-09 | — | DEFA14A | 0001641172-25-026967 | View SEC Doc Filr Page |
| DEFM14A | 2025-09-08 | — | DEFM14A | 0001641172-25-026774 | View SEC Doc Filr Page |
| PREM14A | 2025-08-26 | 2025-08-26 | PREM14A | 0001641172-25-025582 | View SEC Doc Filr Page |